An observational study in Hip Arthropathy, Hip Osteoarthritis and Hip Arthritis, sponsored by EUROS. Active, not recruiting at 3 sites in France. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2024-08-28.
Sponsored by EUROS · Observational
EUROSCUP MOBILE is intended for use in primary and revision total hip replacement surgery.
Hip replacement is intended to provide increased patient mobility and reduce pain by replacing the damages hip joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.
As part of post market vigilance, EUROS will collect data on EUROSCUP MOBILE performances and safety
Post market observational study. This study is retropective and prospective, non comparative.
628 studies on the registry are indexed under Osteoarthritis, Hip; 121 are open to participants now.
This study's enrollment of 147 is close to the median of 141 across 154 observational studies indexed under Osteoarthritis, Hip.
Browse Osteoarthritis, Hip studies →EUROS is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Patient who fulfill the criteria of eligilibilty according to the instructions for use of EUROSCUP MOBILE
Exclusion Criteria:
107 who received cementless version of EUROSCUP MOBILE
Device: hip arthroplasty
40 who received cemented version of EUROSCUP MOBILE
Device: hip arthroplasty
Hip prosthesis surgery
Safety of EUROSCUP MOBILE
Collect the safety of the device trought complications occurence rate
Time frame: 1 year
Radiological performances of EUROSCUP MOBILE
Collect the performances of the device trought radiological evaluation
Time frame: 1 year
Clinical performances of EUROSCUP MOBILE
Collect the performances of the device trought clinical scores
Time frame: 1 year
Survival of EUROSCUP MOBILE
Assess the survival rate of the device
Time frame: 10 year
Plan to share: No
No publications or documents are linked to this record.
This study is active, not recruiting, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
EUROS